Nalaganje...
The pharmacogenomics of drug resistance to protein kinase inhibitors
Dysregulation of growth factor cell signaling is a major driver of most human cancers. This has led to development of numerous drugs targeting protein kinases, with demonstrated efficacy in the treatment of a wide spectrum of cancers. Despite their high initial response rates and survival benefits,...
Shranjeno v:
| izdano v: | Drug Resist Updat |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5022787/ https://ncbi.nlm.nih.gov/pubmed/27620953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drup.2016.06.008 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|